Stoke Therapeutics, Inc. (STOK) - Balance Sheet Statement

Home
STOK
Financials

11.68 (USD) • At close December 20, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2023	2022	2021	2020	2019	2018	2017
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	191.442	113.556	144.895	287.308	222.471	105.399	1.797
Short Term Investments Numbers are in millions	9.952	116.039	74.915	0	0	0	0
Cash and Short Term Investments Numbers are in millions	201.394	229.595	219.81	287.308	222.471	105.399	1.797
Net Receivables Numbers are in millions	0.064	0.588	0.132	0.006	0.281	0.196	0
Inventory Numbers are in millions	0	10.932	0	0	0	0	0
Other Current Assets Numbers are in millions	13.881	13.887	9.276	6.616	6.562	0.548	0.113
Total Current Assets Numbers are in millions	215.339	244.07	229.218	293.93	226.033	106.143	1.91
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	12.434	11.428	9.078	3.79	2.512	1.192	0.473
Goodwill Numbers are in millions	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0	0	0	0	0	0	0
Long Term Investments Numbers are in millions	0	0.569	0.569	0.205	0.205	0.204	0.056
Tax Assets Numbers are in millions	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	0.569	0	0	0	0	0	0
Total Non-Current Assets Numbers are in millions	13.003	11.997	9.647	3.995	2.717	1.396	0.529
Total Assets Numbers are in millions	228.342	256.067	238.865	297.925	228.75	107.539	2.439
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	1.695	0.766	2.385	1.495	0.751	1.071	0.141
Short Term Debt Numbers are in millions	2.388	2.359	1.507	1.066	0	0	3
Tax Payables Numbers are in millions	0	0	0	0	0	0	0
Deferred Revenue Numbers are in millions	15.309	14.88	12.707	-1.066	0	0	-3
Other Current Liabilities Numbers are in millions	11.753	13.389	13.247	8.864	3.35	1.396	0.574
Total Current Liabilities Numbers are in millions	30.819	31.394	17.139	11.425	4.101	2.467	3.715
Non-Current Liabilities:
Long Term Debt Numbers are in millions	0	0	0	0	0	0	0
Deferred Revenue Non-Current Numbers are in millions	33.074	36.856	0	0	0	0	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	-2.717	0	0	0	0	0
Other Non-Current Liabilities Numbers are in millions	4.884	2.968	3.949	0.422	0.221	0.004	0.016
Total Non-Current Liabilities Numbers are in millions	37.958	39.824	3.949	0.422	0.221	0.004	0.016
Total Liabilities Numbers are in millions	68.777	71.218	21.088	11.847	4.322	2.471	3.731
Equity:
Preferred Stock Numbers are in millions	0	0	0	0	0	0.002	0.005
Common Stock Numbers are in millions	0.005	0.004	0.004	0.004	0.003	0.001	0.001
Retained Earnings Numbers are in millions	-401.849	-297.15	-196.083	-110.278	-58.035	-25.71	-13.189
Accumulated Other Comprehensive Income/Loss Numbers are in millions	-0.024	-1.175	-0.168	-0	0	-0.379	-0.172
Other Total Stockholders Equity Numbers are in millions	561.433	483.17	414.024	396.352	282.46	130.776	11.891
Total Shareholders Equity Numbers are in millions	159.565	184.849	217.777	286.078	224.428	105.068	-1.292
Total Equity Numbers are in millions	159.565	184.849	217.777	286.078	224.428	105.068	-1.292
Total Liabilities & Shareholders Equity Numbers are in millions	228.342	256.067	238.865	297.925	228.75	107.539	2.439

Stoke Therapeutics, Inc.

NASDAQ:STOK Add to watchlist

NASDAQ:STOK